Dr. Samir Melki MD shared a post with Public Health |  |
 | Dr. Samir Melki MD shared Dr. Samir Melki MD's post with you. |
| Dr. Samir Melki MD: The FDA is considering approving gene therapy to treat a type of hereditary eye disorder. The treatment called luxturna will be used to treat leber congenital amaurosis. People with this disorder eventually lose vision. A recent study shows that gene therapy improved vision in nearly all leber patients. Read more: http://ow.ly/iUf930h #genetherapy #blindness #luxturna #eyedisorder #vision #bostoneyedoctor #bostonophthalmologi  View post |
You're receiving this email because you are subscribed to Public Health on Google+.
Mute Dr. Samir Melki MD to stop receiving notifications from them. Change what notifications you receive from this community. This notification was sent to kukash@gmail.com. Go to your notification delivery settings to update your address. Unsubscribe from these emails.
Google Inc., 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA
Google Inc., 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA
